4//SEC Filing
Colella Giovanni M. 4
Accession 0001140361-17-032441
CIK 0001433714other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:38 PM ET
Size
23.7 KB
Accession
0001140361-17-032441
Insider Transaction Report
Form 4
Colella Giovanni M.
DirectorCEO and Co-Founder10% Owner
Transactions
- Conversion
Class A Common Stock
2017-08-15−14,700→ 4,636,991 total(indirect: By Trust)Exercise: $0.00→ Class B Common Stock (14,700 underlying) - Sale
Class B Common Stock
2017-08-14$4.03/sh−9,100$36,705→ 22,220 total(indirect: By Trust) - Sale
Class B Common Stock
2017-08-15$4.05/sh−14,700$59,582→ 22,220 total(indirect: By Trust) - Conversion
Class A Common Stock
2017-08-14−9,100→ 4,651,691 total(indirect: By Trust)Exercise: $0.00→ Class B Common Stock (9,100 underlying) - Conversion
Class B Common Stock
2017-08-14+9,100→ 31,320 total(indirect: By Trust) - Conversion
Class B Common Stock
2017-08-15+14,700→ 36,920 total(indirect: By Trust)
Holdings
- 160,443(indirect: By Trust)
Class A Common Stock
Exercise: $0.00→ Class B Common Stock (160,443 underlying) - 160,443(indirect: By Trust)
Class A Common Stock
Exercise: $0.00→ Class B Common Stock (160,443 underlying) - 509,638(indirect: By Trust)
Class A Common Stock
Exercise: $0.00→ Class B Common Stock (509,638 underlying) - 78,906
Class B Common Stock
- 509,638(indirect: By Trust)
Class A Common Stock
Exercise: $0.00→ Class B Common Stock (509,638 underlying)
Footnotes (8)
- [F1]Reporting Person serves as a co-trustee.
- [F2]Represents the aggregate of sales effected on the same day at different prices.
- [F3]Represents the weighted average sales price per share. The shares sold at prices ranging from $3.90 to $4.125 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F4]Represents the weighted average sales price per share. The shares sold at prices ranging from $4.00 to $4.10 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.
- [F5]Each share of Class A Common Stock is convertible, at any time at the option of the holder, into one (1) share of Class B Common Stock. In addition, each share of Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the transfer, whether or not for value, that occurs after the closing of the IPO to any transferee who is not a "Permitted Transferee", as defined in the Issuer's Restated Certificate of Incorporation in effect as of the date hereof. The shares of Class A Common Stock have no expiration date.
- [F6]Each share of the Issuer's Class A Common Stock will convert automatically into one (1) share of Class B Common Stock upon the earliest to occur of the following: (a) the first date on which the number of shares of Class A Common Stock then outstanding is less than 15,340,384 shares, (b) March 19, 2024, or (c) a time and date approved in writing by holders of at least a majority of the then-outstanding shares of Class A Common Stock. The shares of Class A Common Stock and Class B Common Stock have no expiration date.
- [F7]Reporting Person serves as trustee and sole beneficiary.
- [F8]Reporting Person's spouse serves as trustee and sole beneficiary.
Documents
Issuer
CASTLIGHT HEALTH, INC.
CIK 0001433714
Entity typeother
Related Parties
1- filerCIK 0001601554
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:38 PM ET
- Size
- 23.7 KB